Screener
Elanco Animal Health Inc. ELAN Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 55.4%+0.6pp | 55.1%+0.2pp | 55%+0.1pp | 55%+0.3pp | 54.7%-0.5pp | |
| Net margin | -4%-13.8pp | -4.9%-13.6pp | -4.9%-12.7pp | 1%-3.6pp | 9.9%+37.8pp | |
| Returns | ||||||
| Return on equity | -3%-9.9pp | -3.8%-9.9pp | -3.7%-9.3pp | 0.7%-2.6pp | 7%+25.7pp | |
| Return on invested capital | 0.8%— | 0.4%— | -0%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.1×-0.5× | 2.2×-0.6× | 2.2×-0.3× | 2.4×-0.1× | 2.6×-0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.6×0.0× | 0.7×0.0× | 0.7×-0.1× | 0.6×0.0× | 0.7×-0.3× | |
| Net debt / EBITDA | 4.8×— | 5.3×— | 5.8×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $13.02-3.9% | $12.85+0.9% | $13.19+7.6% | $13.58+3.7% | $13.55+12.7% | |
| Valuation | ||||||
| Market capitalization | $13.1B+89.0% | $11.9B+128% | $11.24B+87.8% | $10.01B+37.8% | $6.71B-5.9% | |
| Price / sales | 2.6×+1.1× | 2.4×+1.3× | 2.4×+1.0× | 2.2×+0.5× | 1.5×-0.1× | |
| Price / book | 2×+1.0× | 1.8×+1.0× | 1.7×+0.7× | 1.5×+0.4× | 1×-0.2× | |
| EV / EBITDA | 21.7×— | 21.6×— | 22.4×— | —— | —— |
FAQ
- Where do Elanco Animal Health Inc.'s ratios come from?
- Every ratio is computed from Elanco Animal Health Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
